<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04563429</url>
  </required_header>
  <id_info>
    <org_study_id>SHEBA-20-7281-LL-CTIL</org_study_id>
    <nct_id>NCT04563429</nct_id>
  </id_info>
  <brief_title>Vitamin A for BPD Prevention</brief_title>
  <official_title>Vitamin A Oral Supplementation as a Preventive Treatment for Chronic Lung Disease Among Infants Born Before 29 Weeks of Gestation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sheba Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sheba Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic bronchopulmonary dysplasia (BPD) is a very common complication in preterm infants&#xD;
      born at a young gestational age, and is a serious disease that impairs respiratory long-term&#xD;
      outcome and is associated with higher-frequency neurodevelopmental injury. Lowering the&#xD;
      incidence of BPD may improve the health of the preterm babies and neurodevelopmental delay of&#xD;
      preterm infants.Vitamin A deficiency may be one of the factors associated with the&#xD;
      development of BPD in preterm infants. According to the literature, oral vitamin A&#xD;
      administration can lower the incidence of BPD. In our study we plan to give 5000 units of&#xD;
      retinol / dose / day, every day for 28 days.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2020</start_date>
  <completion_date type="Anticipated">October 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of BPD at 28 days</measure>
    <time_frame>28 days of life</time_frame>
    <description>Chronic pulmonary desease of prematue babies</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of mortality at 28 days</measure>
    <time_frame>28 days of life</time_frame>
    <description>Death before 28 days of life</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>The Relationship Between Oral Vitamin A Administration and the Incidence of BPD in Preterm Infants Born Before Week 29 of Pregnancy</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Oral Vitamin A</intervention_name>
    <description>Oral administration of 5000 EU of Vitamin A during first 28 days of life</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Premature babies under 29 weeks, at any birth weight&#xD;
&#xD;
          -  A preterm baby is less than 4 days to life&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Major congenital malformations&#xD;
&#xD;
          -  Known chromosomal disorders&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leah Leibovich, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Chaim Sheba Medical Center, Tel Hashomer, Israel</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Leah Leibovitch, MD</last_name>
    <phone>+972526667325</phone>
    <email>leah.leibovitch@sheba.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Liudmila Lo Schiavo Winer, MD</last_name>
    <phone>+972503367233</phone>
    <email>Liudmila.LoSchiavo@sheba.health.gov.il</email>
  </overall_contact_backup>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>September 22, 2020</study_first_submitted>
  <study_first_submitted_qc>September 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2020</study_first_posted>
  <last_update_submitted>September 22, 2020</last_update_submitted>
  <last_update_submitted_qc>September 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sheba Medical Center</investigator_affiliation>
    <investigator_full_name>Dr. Leah Leibovitch MD</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamin A</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

